1. World Health Organization’s Global Survey of Maternal and Perinatal Health
URADCA partnered with the World Health Organization for the implementation of the Global Survey of Maternal and Perinatal Health, which was conducted between 2004 and 2008. Seven African countries participated in the study (Algeria, Angola, DRC, Niger, Nigeria, Kenya and Uganda) and covered 131 randomly selected health facilities which resulted in observation of 83,439 health facility deliveries. URADCA provided data analysis for all participating countries. This cutting-edge research led to many publications and several WHO policy briefs which have impacted maternal and perinatal health in Africa. URADCA participated in the authorship of one of the key manuscripts: Shah A, Fawole B, M'Imunya JM, Amokrane F, Nafiou I, Wolomby JJ, Mugerwa K, Isilda Neves h, Nguti R, et al. Cesarean delivery outcomes from the WHO global survey on maternal and perinatal health in Africa. Int J Gynecol Obstet 2009; doi: 10.1016.
2. Endline evaluation survey for the USAID Bureau for Global Health’s flagship MCHIP
Maternal and Child Health Integrated Program (MCHIP) (https://www.mchip.net/) implemented by Jhpiego in 50 countries.
URADCA won the tender to conduct the endline survey for the Kenya component of the MCHIP program. In Kenya, MCHIP provided technical assistance to the Ministry of Health Department of Family Health and was implemented in more than 10 focus counties. URADCA developed the survey protocol, applied and received scientific and ethics approval, led implementation in the field and performed data analysis and final report writing. As part of the MCHIP Kenya final evaluation, URADCA conducted a formative research on handwashing knowledge, attitudes and practices in Korogocho slums (Nairobi county) and Bondo sub-county (Siaya County.)
3. Microbicide Preparedness studies funded by the International Partnership for Microbicides (IPM)
Between 2005 and 2007, URADCA collaborated with the IPM to conduct microbicide (female-controlled HIV prevention technologies) preparedness studies in Kenya. This involved identification of potential research sites, research site assessments and determining the feasibility of conducting microbicide clinical trials in Kenya. These preparedness studies were extremely successful following which many research institutions in Kenya, including the International Centre for Reproductive Health (ICRH), KEMRI and University of Nairobi, were selected to implement safety and efficacy trials of candidate microbicide products. A summary of these initial microbicide studies can be retrieved from this site: http://www.global-campaign.org/clientfiles/FS21-Kenya.pdf . As a follow up, URADCA implemented a cross-sectional HIV incidence study in Suba (Nyanza) and Mukuru (Nairobi) in 2007.